InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Scheibler Lukas, Directeur de l'Innovation. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 20 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €858k. History available since 10 June 2021. The latest transaction was filed on 1 December 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Scheibler Lukas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
10,000 shares@ US$13.8514.1% of flowCommon StockSEC:0001127602-23-028966:0
10,000 shares@ US$60.0060.9% of flowCommon StockSEC:0001127602-23-028966:1
1,756 shares@ US$43.017.8% of flowCommon StockSEC:0001127602-23-023845:0
9,886 shares0Common StockSEC:0000899243-23-005789:0
678 shares@ US$51.213.6% of flowCommon StockSEC:0001127602-23-005162:0
542 shares@ US$52.772.9% of flowCommon StockSEC:0001127602-23-002688:0
2,015 shares@ US$52.0510.7% of flowCommon StockSEC:0001127602-23-002135:0
22,580 shares0Common StockSEC:0001127602-23-001500:0
1,875 shares0Common StockSEC:0001127602-22-016013:0
609 shares@ US$13.851.1% of flowCommon StockSEC:0001127602-22-011670:0
3,504 shares@ US$13.856.4% of flowCommon StockSEC:0001127602-22-011526:0
11,496 shares@ US$13.8520.8% of flowCommon StockSEC:0001127602-22-011246:0
720 shares@ US$26.732.4% of flowCommon StockSEC:0001127602-22-005041:0
1,666 shares@ US$46.809.9% of flowCommon StockSEC:0001127602-22-004908:0
678 shares@ US$47.124.0% of flowCommon StockSEC:0001127602-22-004774:0
10,000 shares@ US$13.8517.5% of flowCommon StockSEC:0001127602-22-004067:0
642 shares@ US$38.593.2% of flowCommon StockSEC:0001127602-22-002804:0
26,051 shares0Common StockSEC:0001127602-22-002071:0
3,021 shares@ US$26.7310.3% of flowCommon StockSEC:0001127602-22-001964:0
3,417 shares@ US$60.0024.3% of flowCommon StockSEC:0001127602-21-019710:0
20 of 20 declarations
About Scheibler Lukas
SCHEIBLER LUKAS is Directeur de l'Innovation and appears in 20 filings in total. Across the 20 sampled filings, they relate to Apellis Pharmaceuticals, Inc., with EUR 858014 of sales and no purchases, between 2021-06-11 and 2023-12-05, and the most frequent transaction nature is option exercise.
